lung cancer

Researchers studying lung cancer cell lines found that chromatin remodeling underlies one type of osimertinib resistance.

Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.

Probing the protein landscape in lung cancers reveals new therapeutic insights.

An artificial intelligence program called a neural network exceeds radiologists’ ability to detect malignancies, but more testing is needed before using the program clinically.

Human lung cancer cells can form an invasive pack that coordinates its movement during metastasis.  

The scientist and clinician helped develop a new form of cancer therapy, using a monoclonal antibody to treat head, neck, colorectal, and lung cancers.

Better treatment and diagnoses have helped more people survive, but economic disparities in outcomes for some preventable cancers have gotten worse.

A small, in vitro study concludes that e-cigarette vapor harms macrophages taken from human lung tissue.

Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  

The test can pick up several types of cancer, including pancreatic and ovarian, years before symptoms appear.

Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.

By removing a single gene, researchers change the developmental fate of tumor cells in mice.  

The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

Scientists produce a detailed genomic map of mutations and epigenetic changes associated with smoking tobacco across 17 tumor types. 

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

Researchers and regulators reflect on the progress that has been made in preventing tobacco-related disease in the 50 years since the publication of the first U.S. Surgeon General’s report.